Drug price regulation

Jean-Michel Josselin (1) , Laurie Rachet Jacquet (2, 3) , Véronique Raimond (4) , Lise Rochaix (2, 3, 5)

1 CREM - Centre de recherche en économie et management
2 Hospinomics
3 PSE - Paris School of Economics
4 HAS - Haute Autorité de Santé [Saint-Denis La Plaine]
5 PJSE - Paris Jourdan Sciences Economiques

Drug prices are regulated in a legal framework that organizes the negotiation between pharmaceutical firms and a third-party payer responsible for healthcare reimbursement. This regulation aims at compensating for market failures associated with drug specificities. Explicit economic reasoning through the socalled health technology assessment framework is increasingly embedded in the institutional and administrative process of the evaluation procedure leading to market access, pricing and reimbursement for new drugs.

Mots clés: Drug prices; Prices regulation

Domaines: Economies et finances; Gestion et management

Jean-Michel Josselin, Laurie Rachet Jacquet, Véronique Raimond, Lise Rochaix. Drug price regulation. Alain Marciano, Giovanni Battista Ramello. Encyclopedia of Law and Economics, Springer Science+Business Media LLC 2017, pp.1-8, 2017, 978-1-4614-7883-6. ⟨10.1007/978-1-4614-7883-6_714-1⟩. ⟨halshs-01615092⟩